GO:0000398 | mRNA splicing, via spliceosome | 1.89e-06 | 1.85e-02 | 5.253 | 4 | 15 | 128 |
GO:0000389 | mRNA 3'-splice site recognition | 3.52e-06 | 3.44e-02 | 9.253 | 2 | 2 | 4 |
GO:0008380 | RNA splicing | 5.22e-06 | 5.10e-02 | 4.887 | 4 | 21 | 165 |
GO:0005681 | spliceosomal complex | 9.28e-06 | 9.06e-02 | 6.057 | 3 | 8 | 55 |
GO:0071013 | catalytic step 2 spliceosome | 1.27e-05 | 1.24e-01 | 5.908 | 3 | 5 | 61 |
GO:0005654 | nucleoplasm | 2.55e-04 | 1.00e+00 | 2.801 | 5 | 68 | 876 |
GO:0010467 | gene expression | 5.23e-04 | 1.00e+00 | 3.190 | 4 | 49 | 535 |
GO:0003723 | RNA binding | 8.15e-04 | 1.00e+00 | 3.890 | 3 | 22 | 247 |
GO:0005515 | protein binding | 1.01e-03 | 1.00e+00 | 1.244 | 8 | 198 | 4124 |
GO:0001649 | osteoblast differentiation | 1.54e-03 | 1.00e+00 | 5.044 | 2 | 5 | 74 |
GO:0005684 | U2-type spliceosomal complex | 1.64e-03 | 1.00e+00 | 9.253 | 1 | 2 | 2 |
GO:0036289 | peptidyl-serine autophosphorylation | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 3 |
GO:0005634 | nucleus | 2.53e-03 | 1.00e+00 | 1.396 | 7 | 158 | 3246 |
GO:0090170 | regulation of Golgi inheritance | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 4 |
GO:0006397 | mRNA processing | 3.37e-03 | 1.00e+00 | 4.472 | 2 | 12 | 110 |
GO:2000641 | regulation of early endosome to late endosome transport | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 2 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 5 |
GO:0050847 | progesterone receptor signaling pathway | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 2 | 6 |
GO:0001055 | RNA polymerase II activity | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 3 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 2 | 6 |
GO:0032872 | regulation of stress-activated MAPK cascade | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 1 | 7 |
GO:2000147 | positive regulation of cell motility | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 2 | 7 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 2 | 7 |
GO:0004708 | MAP kinase kinase activity | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 2 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 4 | 8 |
GO:0071354 | cellular response to interleukin-6 | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 9 |
GO:0005736 | DNA-directed RNA polymerase I complex | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 4 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 4 | 11 |
GO:0043539 | protein serine/threonine kinase activator activity | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 12 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 3 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 3 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 3 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 3 | 14 |
GO:0070371 | ERK1 and ERK2 cascade | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 1 | 14 |
GO:0016575 | histone deacetylation | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 2 | 14 |
GO:0000188 | inactivation of MAPK activity | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 15 |
GO:0004712 | protein serine/threonine/tyrosine kinase activity | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 2 | 17 |
GO:0030532 | small nuclear ribonucleoprotein complex | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 1 | 17 |
GO:0003899 | DNA-directed RNA polymerase activity | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 3 | 18 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 19 |
GO:0071902 | positive regulation of protein serine/threonine kinase activity | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 2 | 20 |
GO:0032947 | protein complex scaffold | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 2 | 20 |
GO:0071897 | DNA biosynthetic process | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 2 | 20 |
GO:0006370 | 7-methylguanosine mRNA capping | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 6 | 24 |
GO:0097110 | scaffold protein binding | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 1 | 25 |
GO:0006360 | transcription from RNA polymerase I promoter | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 4 | 27 |
GO:0044822 | poly(A) RNA binding | 2.24e-02 | 1.00e+00 | 2.196 | 3 | 45 | 799 |
GO:0009898 | cytoplasmic side of plasma membrane | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 3 | 28 |
GO:0006383 | transcription from RNA polymerase III promoter | 2.35e-02 | 1.00e+00 | 5.395 | 1 | 6 | 29 |
GO:0005778 | peroxisomal membrane | 2.35e-02 | 1.00e+00 | 5.395 | 1 | 3 | 29 |
GO:0007254 | JNK cascade | 2.75e-02 | 1.00e+00 | 5.166 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 5 | 35 |
GO:0006396 | RNA processing | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 4 | 40 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 6 | 40 |
GO:0000186 | activation of MAPKK activity | 3.31e-02 | 1.00e+00 | 4.896 | 1 | 1 | 41 |
GO:0051403 | stress-activated MAPK cascade | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 2 | 42 |
GO:0032481 | positive regulation of type I interferon production | 3.87e-02 | 1.00e+00 | 4.668 | 1 | 3 | 48 |
GO:0034146 | toll-like receptor 5 signaling pathway | 4.03e-02 | 1.00e+00 | 4.610 | 1 | 3 | 50 |
GO:0034166 | toll-like receptor 10 signaling pathway | 4.03e-02 | 1.00e+00 | 4.610 | 1 | 3 | 50 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 4.18e-02 | 1.00e+00 | 4.553 | 1 | 8 | 52 |
GO:0030165 | PDZ domain binding | 4.18e-02 | 1.00e+00 | 4.553 | 1 | 3 | 52 |
GO:0006289 | nucleotide-excision repair | 4.26e-02 | 1.00e+00 | 4.525 | 1 | 6 | 53 |
GO:0005770 | late endosome | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 2 | 54 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 3 | 55 |
GO:0034162 | toll-like receptor 9 signaling pathway | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 3 | 55 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 3 | 55 |
GO:0004713 | protein tyrosine kinase activity | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 1 | 55 |
GO:0034134 | toll-like receptor 2 signaling pathway | 4.50e-02 | 1.00e+00 | 4.446 | 1 | 3 | 56 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 4.58e-02 | 1.00e+00 | 4.421 | 1 | 2 | 57 |
GO:0042826 | histone deacetylase binding | 4.66e-02 | 1.00e+00 | 4.395 | 1 | 5 | 58 |
GO:0000165 | MAPK cascade | 4.66e-02 | 1.00e+00 | 4.395 | 1 | 3 | 58 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 4.66e-02 | 1.00e+00 | 4.395 | 1 | 2 | 58 |
GO:0034138 | toll-like receptor 3 signaling pathway | 4.73e-02 | 1.00e+00 | 4.371 | 1 | 2 | 59 |
GO:0007265 | Ras protein signal transduction | 4.73e-02 | 1.00e+00 | 4.371 | 1 | 3 | 59 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 4.89e-02 | 1.00e+00 | 4.323 | 1 | 4 | 61 |
GO:0045087 | innate immune response | 4.97e-02 | 1.00e+00 | 2.433 | 2 | 12 | 452 |
GO:0000187 | activation of MAPK activity | 5.05e-02 | 1.00e+00 | 4.276 | 1 | 3 | 63 |
GO:0030308 | negative regulation of cell growth | 5.59e-02 | 1.00e+00 | 4.124 | 1 | 3 | 70 |
GO:0034142 | toll-like receptor 4 signaling pathway | 5.83e-02 | 1.00e+00 | 4.064 | 1 | 3 | 73 |
GO:0005938 | cell cortex | 6.14e-02 | 1.00e+00 | 3.987 | 1 | 6 | 77 |
GO:0030529 | ribonucleoprotein complex | 6.53e-02 | 1.00e+00 | 3.896 | 1 | 5 | 82 |
GO:0002224 | toll-like receptor signaling pathway | 6.60e-02 | 1.00e+00 | 3.878 | 1 | 3 | 83 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 7.07e-02 | 1.00e+00 | 3.778 | 1 | 2 | 89 |
GO:0008286 | insulin receptor signaling pathway | 7.68e-02 | 1.00e+00 | 3.653 | 1 | 2 | 97 |
GO:0005911 | cell-cell junction | 8.21e-02 | 1.00e+00 | 3.553 | 1 | 3 | 104 |
GO:0005769 | early endosome | 8.59e-02 | 1.00e+00 | 3.485 | 1 | 3 | 109 |
GO:0042981 | regulation of apoptotic process | 8.82e-02 | 1.00e+00 | 3.446 | 1 | 4 | 112 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 8.97e-02 | 1.00e+00 | 3.421 | 1 | 2 | 114 |
GO:0007049 | cell cycle | 9.05e-02 | 1.00e+00 | 3.408 | 1 | 8 | 115 |
GO:0005739 | mitochondrion | 9.71e-02 | 1.00e+00 | 1.889 | 2 | 32 | 659 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 1.03e-01 | 1.00e+00 | 3.209 | 1 | 2 | 132 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.11e-01 | 1.00e+00 | 3.104 | 1 | 5 | 142 |
GO:0044212 | transcription regulatory region DNA binding | 1.11e-01 | 1.00e+00 | 3.094 | 1 | 13 | 143 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.25e-01 | 1.00e+00 | 2.922 | 1 | 18 | 161 |
GO:0005874 | microtubule | 1.26e-01 | 1.00e+00 | 2.905 | 1 | 10 | 163 |
GO:0007264 | small GTPase mediated signal transduction | 1.34e-01 | 1.00e+00 | 2.810 | 1 | 8 | 174 |
GO:0000166 | nucleotide binding | 1.35e-01 | 1.00e+00 | 2.794 | 1 | 13 | 176 |
GO:0005737 | cytoplasm | 1.43e-01 | 1.00e+00 | 0.891 | 4 | 127 | 2633 |
GO:0005743 | mitochondrial inner membrane | 1.50e-01 | 1.00e+00 | 2.631 | 1 | 9 | 197 |
GO:0004674 | protein serine/threonine kinase activity | 1.50e-01 | 1.00e+00 | 2.631 | 1 | 8 | 197 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 1.52e-01 | 1.00e+00 | 2.617 | 1 | 8 | 199 |
GO:0006281 | DNA repair | 1.55e-01 | 1.00e+00 | 2.588 | 1 | 24 | 203 |
GO:0019899 | enzyme binding | 1.60e-01 | 1.00e+00 | 2.539 | 1 | 7 | 210 |
GO:0005524 | ATP binding | 1.61e-01 | 1.00e+00 | 1.453 | 2 | 37 | 892 |
GO:0003677 | DNA binding | 1.78e-01 | 1.00e+00 | 1.366 | 2 | 52 | 947 |
GO:0007411 | axon guidance | 1.79e-01 | 1.00e+00 | 2.365 | 1 | 8 | 237 |
GO:0008285 | negative regulation of cell proliferation | 2.06e-01 | 1.00e+00 | 2.140 | 1 | 11 | 277 |
GO:0005925 | focal adhesion | 2.09e-01 | 1.00e+00 | 2.114 | 1 | 14 | 282 |
GO:0009986 | cell surface | 2.15e-01 | 1.00e+00 | 2.069 | 1 | 5 | 291 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.32e-01 | 1.00e+00 | 1.945 | 1 | 17 | 317 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.48e-01 | 1.00e+00 | 1.840 | 1 | 23 | 341 |
GO:0048471 | perinuclear region of cytoplasm | 2.49e-01 | 1.00e+00 | 1.827 | 1 | 11 | 344 |
GO:0016020 | membrane | 2.59e-01 | 1.00e+00 | 1.016 | 2 | 56 | 1207 |
GO:0005730 | nucleolus | 2.63e-01 | 1.00e+00 | 1.004 | 2 | 74 | 1217 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.70e-01 | 1.00e+00 | 1.695 | 1 | 21 | 377 |
GO:0005783 | endoplasmic reticulum | 2.73e-01 | 1.00e+00 | 1.680 | 1 | 12 | 381 |
GO:0005794 | Golgi apparatus | 2.94e-01 | 1.00e+00 | 1.556 | 1 | 6 | 415 |
GO:0016032 | viral process | 3.01e-01 | 1.00e+00 | 1.512 | 1 | 30 | 428 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.18e-01 | 1.00e+00 | 1.421 | 1 | 29 | 456 |
GO:0005887 | integral component of plasma membrane | 3.85e-01 | 1.00e+00 | 1.086 | 1 | 8 | 575 |
GO:0007165 | signal transduction | 4.07e-01 | 1.00e+00 | 0.982 | 1 | 24 | 618 |
GO:0005576 | extracellular region | 4.30e-01 | 1.00e+00 | 0.881 | 1 | 15 | 663 |
GO:0005829 | cytosol | 4.46e-01 | 1.00e+00 | 0.450 | 2 | 88 | 1787 |
GO:0006355 | regulation of transcription, DNA-templated | 4.56e-01 | 1.00e+00 | 0.772 | 1 | 31 | 715 |
GO:0008270 | zinc ion binding | 4.62e-01 | 1.00e+00 | 0.748 | 1 | 39 | 727 |
GO:0070062 | extracellular vesicular exosome | 7.71e-01 | 1.00e+00 | -0.427 | 1 | 51 | 1641 |